Bayer AG (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
89.26+0.48 (+0.54%)
At close: 11:35 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close88.78
Bid0.00 x 28400
Ask0.00 x 2100
Day's Range88.81 - 90.14
52wk Range83.45 - 127.25
1y Target EstN/A
Market Cap73.77B
P/E Ratio (ttm)16.39
Avg Vol (3m)2,023,298
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Reuters13 hours ago

    Monsanto ally Novozymes sees opportunity, risk in Bayer merger

    Novozymes (NZYMb.CO), already grappling with the consequences of low oil and crop prices, is watching anxiously to see what Bayer's (BAYGn.DE) purchase of Monsanto (MON.N) will mean for the Danish group's ties with its key agricultural partner. Chief Executive Peder Holk Nielsen said in an interview that a merged Bayer-Monsanto could extend the market for the company's smart microbial crop-boosting products, known as inoculants, but added the union also brings uncertainties. Nielsen has not yet held any discussions with Bayer about the future of its strategic tie-up with Monsanto, the BioAg Alliance, but said he expected to do so before the takeover is completed.

  • MarketWatchyesterday

    Acceleron Pharma tabs Bayer exec as next CEO

    Acceleron Pharma Inc. announced Tuesday that founder John Knopf would step down as president and chief executive and be replaced by an executive from Bayer AG . Acceleron announced that Bayer's president ...

  • Market Realistyesterday

    Why Is Monsanto Still Limping? Get Ready for 4Q16 Earnings

    Monsanto (MON) continues to limp days after its merger announcement with Bayer AG. The stock closed at $102 or 25% below Bayer's offer price of $128 as of September 26's closing.